{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T20:28:34Z","timestamp":1772310514984,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thespinejournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Spine Journal"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.spinee.2014.05.010","type":"journal-article","created":{"date-parts":[[2014,5,16]],"date-time":"2014-05-16T21:16:23Z","timestamp":1400274983000},"page":"2929-2937","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["The use of bone morphogenetic protein in thoracolumbar spine procedures: analysis of the MarketScan longitudinal database"],"prefix":"10.1016","volume":"14","author":[{"given":"Anand","family":"Veeravagu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tyler S.","family":"Cole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bowen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John K.","family":"Ratliff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Risha A.","family":"Gidwani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.spinee.2014.05.010_bib1","doi-asserted-by":"crossref","first-page":"547","DOI":"10.5435\/JAAOS-20-09-547","article-title":"Bone morphogenetic protein in spine surgery: current and future uses","volume":"20","author":"Even","year":"2012","journal-title":"J Am Acad Orthop Surg"},{"key":"10.1016\/j.spinee.2014.05.010_bib2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.5312\/wjo.v4.i2.53","article-title":"Bone morphogenetic protein in complex cervical spine surgery: a safe biologic adjunct?","volume":"4","author":"Lebl","year":"2013","journal-title":"World J Orthop"},{"key":"10.1016\/j.spinee.2014.05.010_bib3","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/01.brs.0000206357.88287.5a","article-title":"Influence of rhBMP-2 on the healing patterns associated with allograft interbody constructs in comparison with autograft","volume":"31","author":"Burkus","year":"2006","journal-title":"Spine"},{"issue":"6 Suppl","key":"10.1016\/j.spinee.2014.05.010_bib4","doi-asserted-by":"crossref","first-page":"240S","DOI":"10.1016\/j.spinee.2005.02.014","article-title":"Bone morphogenetic proteins for spinal fusion","volume":"5","author":"Carlisle","year":"2005","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2014.05.010_bib5","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3171\/spi.2005.2.5.0521","article-title":"Anterior cervical discectomy and fusion involving a polyetheretherketone spacer and bone morphogenetic protein","volume":"2","author":"Boakye","year":"2005","journal-title":"J Neurosurg Spine"},{"key":"10.1016\/j.spinee.2014.05.010_bib6","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3171\/spi.2004.1.3.0254","article-title":"Bone morphogenetic proteins in anterior lumbar interbody fusion: old techniques and new technologies. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004","volume":"1","author":"Burkus","year":"2004","journal-title":"J Neurosurg Spine"},{"key":"10.1016\/j.spinee.2014.05.010_bib7","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3928\/0147-7447-20040701-12","article-title":"The effectiveness of rhBMP-2 in replacing autograft: an integrated analysis of three human spine studies","volume":"27","author":"Burkus","year":"2004","journal-title":"Orthopedics"},{"key":"10.1016\/j.spinee.2014.05.010_bib8","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.2106\/JBJS.G.01157","article-title":"Recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge with an osteoconductive bulking agent in posterolateral arthrodesis with instrumentation. A prospective randomized trial","volume":"91","author":"Dawson","year":"2009","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.spinee.2014.05.010_bib9","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1097\/00007632-200212010-00005","article-title":"Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies","volume":"27","author":"Boden","year":"2002","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2014.05.010_bib10","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/00007632-200002010-00020","article-title":"The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: a preliminary report","volume":"25","author":"Boden","year":"2000","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2014.05.010_bib11","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1227\/NEU.0000000000000018","article-title":"Cancer after spinal fusion: the role of bone morphogenetic protein","volume":"73","author":"Lad","year":"2013","journal-title":"Neurosurgery"},{"key":"10.1016\/j.spinee.2014.05.010_bib12","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.spinee.2011.09.029","article-title":"Reply to \u201cA critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned\u201d","volume":"11","author":"Dimar","year":"2011","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2014.05.010_bib13","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.spinee.2011.01.017","article-title":"Adjacent vertebral body osteolysis with bone morphogenetic protein use in transforaminal lumbar interbody fusion","volume":"11","author":"Helgeson","year":"2011","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2014.05.010_bib14","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.spinee.2011.05.009","article-title":"Folly of FDA-approval studies for bone morphogenetic protein","volume":"11","author":"Mirza","year":"2011","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2014.05.010_bib15","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.spinee.2011.05.001","article-title":"Resetting standards for sponsored research: do conflicts influence results?","volume":"11","author":"Spengler","year":"2011","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2014.05.010_bib16","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.spinee.2011.04.023","article-title":"A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned","volume":"11","author":"Carragee","year":"2011","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2014.05.010_bib17","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.spinee.2011.03.022","article-title":"Another complication associated with rhBMP-2?","volume":"11","author":"Kang","year":"2011","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2014.05.010_bib18","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.spinee.2010.05.016","article-title":"Complications with recombinant human bone morphogenetic protein-2 in posterolateral spine fusion associated with a dural tear","volume":"11","author":"Glassman","year":"2011","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2014.05.010_bib19","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.spinee.2012.11.002","article-title":"A biologic without guidelines: the YODA project and the future of bone morphogenetic protein-2 research","volume":"12","author":"Carragee","year":"2012","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2014.05.010_bib20","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"key":"10.1016\/j.spinee.2014.05.010_bib21","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.spinee.2014.05.010_bib22","series-title":"Computerized matching of controls. Section of Biostatistics Technical Report 56","author":"Bergstralh","year":"1995"},{"key":"10.1016\/j.spinee.2014.05.010_bib23","doi-asserted-by":"crossref","first-page":"890","DOI":"10.7326\/0003-4819-158-12-201306180-00006","article-title":"Effectiveness and harms of recombinant human bone morphogenetic protein-2 in spine fusion: a systematic review and meta-analysis","volume":"158","author":"Fu","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.spinee.2014.05.010_bib24","doi-asserted-by":"crossref","first-page":"877","DOI":"10.7326\/0003-4819-158-12-201306180-00005","article-title":"Safety and effectiveness of recombinant human bone morphogenetic protein-2 for spinal fusion: a meta-analysis of individual-participant data","volume":"158","author":"Simmonds","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.spinee.2014.05.010_bib25","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/BRS.0000000000000004","article-title":"Complications of spinal fusion with utilization of bone morphogenetic protein: a systematic review of the literature","volume":"39","author":"Singh","year":"2014","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2014.05.010_bib26","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.spinee.2012.09.040","article-title":"Retrograde ejaculation after anterior lumbar interbody fusion with and without bone morphogenetic protein-2 augmentation: a 10-year cohort controlled study","volume":"12","author":"Comer","year":"2012","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2014.05.010_bib27","unstructured":"Food and Drug Administration OaRDAP. Executive summary for P050036 Medtronic's AMPLIFY rhBMP-2 Matrix. 2010. Available at:\u00a0http:\/\/wwwfdagov\/downloads\/advisorycommittees\/committeesmeetingmaterials\/medicaldevices\/medicaldevicesadvisorycommittee\/orthopaedicandrehabilitationdevicespanel\/ucm220079pdf."},{"key":"10.1016\/j.spinee.2014.05.010_bib28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1055\/s-0031-1298616","article-title":"The use of rhBMP in spine surgery: is there a cancer risk?","volume":"3","author":"Devine","year":"2012","journal-title":"Evid Based Spine Care J"},{"key":"10.1016\/j.spinee.2014.05.010_bib29","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1097\/BRS.0b013e3182a3d3b4","article-title":"Risk of cancer after lumbar fusion surgery with recombinant human bone morphogenic protein-2 (rh-BMP-2)","volume":"38","author":"Cooper","year":"2013","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2014.05.010_bib30","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1097\/BRS.0b013e31820bc9e5","article-title":"Outcomes for single-level lumbar fusion: the role of bone morphogenetic protein","volume":"36","author":"Cahill","year":"2011","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2014.05.010_bib31","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/BRS.0b013e31821bfa3a","article-title":"Use of bone morphogenetic proteins in spinal fusion surgery for older adults with lumbar stenosis: trends, complications, repeat surgery, and charges","volume":"37","author":"Deyo","year":"2012","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2014.05.010_bib32","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1377\/hlthaff.2011.0190","article-title":"\u2018Global trigger tool\u2019 shows that adverse events in hospitals may be ten times greater than previously measured","volume":"30","author":"Classen","year":"2011","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.spinee.2014.05.010_bib33","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2307\/2530647","article-title":"The bias due to incomplete matching","volume":"41","author":"Rosenbaum","year":"1985","journal-title":"Biometrics"},{"key":"10.1016\/j.spinee.2014.05.010_bib34","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.2106\/JBJS.H.00200","article-title":"Clinical and radiographic analysis of an optimized rhBMP-2 formulation as an autograft replacement in posterolateral lumbar spine arthrodesis","volume":"91","author":"Dimar","year":"2009","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.spinee.2014.05.010_bib35","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1097\/01.brs.0000240715.78657.81","article-title":"Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2\/compression resistant matrix versus iliac crest bone graft","volume":"31","author":"Dimar","year":"2006","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2014.05.010_bib36","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1097\/01.BRS.0000065486.22141.CA","article-title":"A prospective, randomized, controlled cervical fusion study using recombinant human bone morphogenetic protein-2 with the CORNERSTONE-SR allograft ring and the ATLANTIS anterior cervical plate","volume":"28","author":"Baskin","year":"2003","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2014.05.010_bib37","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00024720-200210000-00001","article-title":"Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages","volume":"15","author":"Burkus","year":"2002","journal-title":"J Spinal Disord Tech"},{"key":"10.1016\/j.spinee.2014.05.010_bib38","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.spinee.2011.02.013","article-title":"Retrograde ejaculation after anterior lumbar interbody fusion using rhBMP-2: a cohort controlled study","volume":"11","author":"Carragee","year":"2011","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2014.05.010_bib39","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.spinee.2009.04.004","article-title":"Complications associated with single-level transforaminal lumbar interbody fusion","volume":"9","author":"Rihn","year":"2009","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2014.05.010_bib40","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.spinee.2012.10.035","article-title":"Impact of bone morphogenetic proteins on frequency of revision surgery, use of autograft bone, and total hospital charges in surgery for lumbar degenerative disease: review of the Nationwide Inpatient Sample from 2002 to 2008","volume":"14","author":"Dagostino","year":"2014","journal-title":"Spine J"}],"container-title":["The Spine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1529943014004720?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1529943014004720?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T14:52:19Z","timestamp":1597848739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1529943014004720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S1529943014004720"],"URL":"https:\/\/doi.org\/10.1016\/j.spinee.2014.05.010","relation":{},"ISSN":["1529-9430"],"issn-type":[{"value":"1529-9430","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The use of bone morphogenetic protein in thoracolumbar spine procedures: analysis of the MarketScan longitudinal database","name":"articletitle","label":"Article Title"},{"value":"The Spine Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.spinee.2014.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}